News

Filter

Current filters:

Taxol

1 to 9 of 709 results

Novelos shares slump 82% as pivotal Ph III lung cancer trial fails to meet primary survival endpoint

25-02-2010

Massachusetts, USA-based Novelos Therapeutic saw its share price plummet 82% to just $0.30, after the…

CarboplatinOncologyPaclitaxelParaplatinPharmaceuticalTaxol

Phyton Biotech acquires assets of Natural Pharmaceuticals

13-10-2009

USA-based Phyton Biotech, an affiliate of Phyton Inc, has purchased the assets of Natural Pharmaceuticals,…

BiotechnologyGenericsMergers & AcquisitionsNorth AmericaOncologyPaclitaxelPharmaceuticalTaxol

“Higher margin” European anti-cancer sales targeted for 2010 by China’s Taihua

30-09-2009

The AIM-quoted Chinese pharmaceutical manufacturer Taihua has disclosed initial details of plans for…

Asia-PacificEuropeGenericsOncologyPaclitaxelTaxol

Pfizer halts Sutent Ph III breast cancer study

03-06-2009

World drug giant Pfizer has discontinued a Phase III study testing Sutent (sunitinib malate) plus paclitaxel…

AvastinbevacizumabcapecitabinePaclitaxelPfizerRocheSunitinib MalateSutentTaxolXeloda

1 to 9 of 709 results

Back to top